Envian Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 2 Months
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 1.75 Cr
- Satisfied Charges ₹ 1.85 Cr
- Revenue Growth 4.61%
- Profit Growth 0.63%
- Ebitda 3.71%
- Net Worth 58.61%
- Total Assets 101.76%
About Envian Life Sciences
Envian Life Sciences Private Limited (ELSPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 December 2015 (Nine years and two months 8 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.75 Cr. The company has closed loans amounting to ₹1.85 Cr, as per Ministry of Corporate Affairs (MCA) records.
Tama Chakraborty and Varati Chakraborty serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74900DL2015PTC288674
- Company No.
288674
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Dec 2015
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Envian Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tama Chakraborty  | Director | 19-Dec-2015 | Current |
| Varati Chakraborty | Director | 03-Mar-2016 | Current |
Financial Performance of Envian Life Sciences.
Envian Life Sciences Private Limited, for the financial year ended 2019, experienced modest growth in revenue, with a 4.61% increase. The company also saw a slight improvement in profitability, with a 0.63% increase in profit. The company's net worth Soared by an impressive increase of 58.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Envian Life Sciences?
In 2018, Envian Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹17.50 M
₹18.50 M
Charges Breakdown by Lending Institutions
- Others : 1.75 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Jan 2020 | Others | ₹1.25 Cr | Open |
| 13 Jan 2020 | Others | ₹5.00 M | Open |
| 29 May 2019 | Karnataka Bank Ltd. | ₹6.50 M | Satisfied |
| 28 Mar 2019 | Karnataka Bank Ltd. | ₹7.50 M | Satisfied |
| 02 Apr 2016 | Karnataka Bank Ltd. | ₹4.50 M | Satisfied |
How Many Employees Work at Envian Life Sciences?
Envian Life Sciences has a workforce of 20 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Envian Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Envian Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
